Charalampos (Harris) Lazaris, Ph.D.
@chlazaris.bsky.social
Senior Data Scientist, Oncology Data Science at Novartis. Interested in gene regulation and deregulation in cancer. Drugging transcription. Views are my own.
Honored to join the Keystone Symposia Fellows Class of 2026! Grateful to @iannisaifantis1, @artsinyc, Matt Shirley & colleagues from @nyugrossman, @WhiteheadInst, and @broadinstitute for their support. Looking forward to what’s ahead!
keypoint.keystonesymposia.org/home/welcomi... @KeystoneSymp
keypoint.keystonesymposia.org/home/welcomi... @KeystoneSymp
Welcoming the Keystone Symposia Fellow's Class of 2026!
The Keystone Symposia Fellows Class of 2026 is announced, showcasing rising stars in biomedical research across the United States for this formative leadership training program.
keypoint.keystonesymposia.org
January 7, 2026 at 1:38 PM
Honored to join the Keystone Symposia Fellows Class of 2026! Grateful to @iannisaifantis1, @artsinyc, Matt Shirley & colleagues from @nyugrossman, @WhiteheadInst, and @broadinstitute for their support. Looking forward to what’s ahead!
keypoint.keystonesymposia.org/home/welcomi... @KeystoneSymp
keypoint.keystonesymposia.org/home/welcomi... @KeystoneSymp
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Three cheers for three KI cancer research projects in this year’s #STATMadness. Vote now for revolutionizing chemotherapy, implantable microparticles and early lung cancer detection:
Details👇voting 👉 buff.ly/T1VqmBu
<a href="https://bsky.app/profile/did:plc:dawci6skpmelnlja3lygz3p7" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@statnews.com
Details👇voting 👉 buff.ly/T1VqmBu
<a href="https://bsky.app/profile/did:plc:dawci6skpmelnlja3lygz3p7" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@statnews.com
March 3, 2025 at 5:05 PM
Three cheers for three KI cancer research projects in this year’s #STATMadness. Vote now for revolutionizing chemotherapy, implantable microparticles and early lung cancer detection:
Details👇voting 👉 buff.ly/T1VqmBu
<a href="https://bsky.app/profile/did:plc:dawci6skpmelnlja3lygz3p7" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@statnews.com
Details👇voting 👉 buff.ly/T1VqmBu
<a href="https://bsky.app/profile/did:plc:dawci6skpmelnlja3lygz3p7" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@statnews.com
Reposted by Charalampos (Harris) Lazaris, Ph.D.
#REVIEW 🚨
In our Feb. issue, Wang & Zhang summarize findings from genetic & epigenetic association studies performed on cohorts of survivors of childhood cancer, providing insights into the long-term adverse effects related to cancer therapy.
📖 👇
https://bit.ly/4eplZ...
In our Feb. issue, Wang & Zhang summarize findings from genetic & epigenetic association studies performed on cohorts of survivors of childhood cancer, providing insights into the long-term adverse effects related to cancer therapy.
📖 👇
https://bit.ly/4eplZ...
Genetic and epigenetic bases of long-term adverse effects of childhood cancer therapy - Nature Reviews Cancer
In this Review, Wang and Zhang summarize the major findings of genetic and epigenetic association studies performed on cohorts of survivors of childhood cancer, which provide insights into the long-term adverse effects related to cancer therapy, and present suggestions....
bit.ly
February 19, 2025 at 3:35 PM
#REVIEW 🚨
In our Feb. issue, Wang & Zhang summarize findings from genetic & epigenetic association studies performed on cohorts of survivors of childhood cancer, providing insights into the long-term adverse effects related to cancer therapy.
📖 👇
https://bit.ly/4eplZ...
In our Feb. issue, Wang & Zhang summarize findings from genetic & epigenetic association studies performed on cohorts of survivors of childhood cancer, providing insights into the long-term adverse effects related to cancer therapy.
📖 👇
https://bit.ly/4eplZ...
Explore emerging research with field leaders @KeystoneSymp Epigenetics in Development and Disease, this March in Banff! keysym.us/KSEpigenetics25 #KSEpigenetics25
Epigenetics in Development and Disease | Keystone Symposia
Join us at the Keystone Symposia on Epigenetics in Development and Disease, March 2025, in Banff, with field leaders!
keysym.us
December 23, 2024 at 4:49 PM
Explore emerging research with field leaders @KeystoneSymp Epigenetics in Development and Disease, this March in Banff! keysym.us/KSEpigenetics25 #KSEpigenetics25
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Reading: @NatureNews Jay Bradner wants to thwart a cancer driver through epigenetics & he's not shy talking about it. http://bit.ly/MyyQNh
Cancer research: Open ambition - Nature
Jay Bradner believes that cancer can be defeated through ...
bit.ly
December 1, 2024 at 4:24 PM
Reading: @NatureNews Jay Bradner wants to thwart a cancer driver through epigenetics & he's not shy talking about it. http://bit.ly/MyyQNh
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Amgen is getting a new chief scientific officer next month, the famed geneticist Howard Chang, as Jay Bradner splits his roles
Amgen names Stanford geneticist and biotech founder to CSO post
Howard Chang, Stanford physician-scientist and biotech co-founder, will become Amgen's new chief science officer.
endpts.com
November 21, 2024 at 3:50 AM
Amgen is getting a new chief scientific officer next month, the famed geneticist Howard Chang, as Jay Bradner splits his roles
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Gene regulation involves thousands of proteins that bind DNA, yet comprehensively mapping these is challenging. Our paper in Nature Genetics describes ChIP-DIP, a method for genome-wide mapping of hundreds of DNA-protein interactions in a single experiment.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
ChIP-DIP maps binding of hundreds of proteins to DNA simultaneously and identifies diverse gene regulatory elements - Nature Genetics
ChIP-DIP (ChIP done in parallel) is a highly multiplex assay for protein–DNA binding, scalable to hundreds of proteins including modified histones, chromatin regulators and transcription factors, offe...
www.nature.com
November 27, 2024 at 4:13 AM
Gene regulation involves thousands of proteins that bind DNA, yet comprehensively mapping these is challenging. Our paper in Nature Genetics describes ChIP-DIP, a method for genome-wide mapping of hundreds of DNA-protein interactions in a single experiment.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Biology of Genomes 2025 is coming up:
- meeting dates: May 6 - 10, 2025
- abstract deadline: Feb 14, 2025
We hope to see you there for another great meeting with a fantastic speaker lineup!
meetings.cshl.edu/meetings.asp...
- meeting dates: May 6 - 10, 2025
- abstract deadline: Feb 14, 2025
We hope to see you there for another great meeting with a fantastic speaker lineup!
meetings.cshl.edu/meetings.asp...
Biology of Genomes
Cold Spring Harbor Laboratory Meetings & Courses -- a private, non-profit institution with research programs in cancer, neuroscience, plant biology, genomics, bioinformatics.
meetings.cshl.edu
December 3, 2024 at 7:21 PM
Biology of Genomes 2025 is coming up:
- meeting dates: May 6 - 10, 2025
- abstract deadline: Feb 14, 2025
We hope to see you there for another great meeting with a fantastic speaker lineup!
meetings.cshl.edu/meetings.asp...
- meeting dates: May 6 - 10, 2025
- abstract deadline: Feb 14, 2025
We hope to see you there for another great meeting with a fantastic speaker lineup!
meetings.cshl.edu/meetings.asp...
Reposted by Charalampos (Harris) Lazaris, Ph.D.
December 6, 2024 at 7:35 PM
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪
There are already many articles for which there is more attention on Bluesky than on other comparable micro-blogging sites, meaning the academic community and the general public have clearly adopted Bluesky as one of its core places to disseminate and discuss new research.
A Place of Joy.
A Place of Joy.
December 3, 2024 at 2:10 PM
Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪
Reposted by Charalampos (Harris) Lazaris, Ph.D.
The EFJ will stop posting on X as of January 20, 2025. This Federation of journalists has roughly 30,000 members across 44 countries and they join several other news sources in leaving the social media platform.
www.thelondoneconomic.com/news/media/e...
www.thelondoneconomic.com/news/media/e...
European Federation of Journalists to stop posting content on X
The EFJ represents over 295,000 journalists in 44 countries.
www.thelondoneconomic.com
December 2, 2024 at 2:11 PM
The EFJ will stop posting on X as of January 20, 2025. This Federation of journalists has roughly 30,000 members across 44 countries and they join several other news sources in leaving the social media platform.
www.thelondoneconomic.com/news/media/e...
www.thelondoneconomic.com/news/media/e...